Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St set to open lower as oil, bond yields tick up
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Arbutus Biopharma (ABUS) Misses Q2 EPS by 5c
August 2, 2018 4:01 PM EDTArbutus Biopharma (NASDAQ: ABUS) reported Q2 EPS of ($0.44), $0.05 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1 million.
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.
... More